Janssen Presents Initial Results for CMA CAR-TTherapy JNJ-4528 Showing Early, Deep and High Responses in the Treatment of Relapsed or Refractory Multiple Myeloma

Press/Media

Period7 Dec 2019

Media coverage

1

Media coverage

  • TitleJanssen Presents Initial Results for CMA CAR-TTherapy JNJ-4528 Showing Early, Deep and High Responses in the Treatment of Relapsed or Refractory Multiple Myeloma
    Media name/outletIndia Pharma News
    Country/TerritoryIndia
    Date7/12/19
    PersonsDeepu Madduri